Literature DB >> 23079692

Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.

Karim Makdoumi1, Anders Bäckman, Jes Mortensen, Anders Magnuson, Sven Crafoord.   

Abstract

PURPOSE: To investigate whether ultraviolet light (UVA) at 365 nm can inhibit/eliminate Acanthamoeba growth and if riboflavin would potentiate such an association.
METHODS: Acanthamoeba castellanii in a fluid medium with a concentration of approximately 1.7 × 10(4) protozoa/ml were prepared with (0.01 %) and without riboflavin. Exposure of UVA (dose 5.475 J/cm(2)) took place twice, with each illumination period followed by culturing of 10 μl in peptone yeast-extract glucose (PYG) medium for 7 days. Every suspension prepared had a non-exposed control solution. Determination of Acanthamoeba was conducted daily, by count in Burker chamber days 4 through 7 after exposure. Statistical analysis was done by repeated-measurement ANOVA and post-hoc analysis for unpaired samples.
RESULTS: The exposure of ultraviolet light resulted in an inhibited growth of Acanthamoeba compared to the non-exposed solutions, with a statistically significant reduction over time (p = 0.0003). The addition of riboflavin did not amplify the effect, and there were no tendencies for an interaction effect between UVA and riboflavin.
CONCLUSIONS: The antiprotozoal effect of the UVA wavelength, utilized in CXL, is solely mediated by ultraviolet light, and riboflavin does not seem to amplify the antimicrobial efficacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079692     DOI: 10.1007/s00417-012-2176-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  41 in total

1.  ITS1 sequence variabilities correlate with 18S rDNA sequence types in the genus Acanthamoeba (Protozoa: Amoebozoa).

Authors:  Martina Köhsler; Brigitte Leitner; Marion Blaschitz; Rolf Michel; Horst Aspöck; Julia Walochnik
Journal:  Parasitol Res       Date:  2005-11-01       Impact factor: 2.289

Review 2.  Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: a review.

Authors:  W A M Hijnen; E F Beerendonk; G J Medema
Journal:  Water Res       Date:  2006-01       Impact factor: 11.236

Review 3.  Acanthamoeba: biology and increasing importance in human health.

Authors:  Naveed Ahmed Khan
Journal:  FEMS Microbiol Rev       Date:  2006-07       Impact factor: 16.408

Review 4.  Acanthamoeba keratitis: diagnosis and treatment update 2009.

Authors:  John K G Dart; Valerie P J Saw; Simon Kilvington
Journal:  Am J Ophthalmol       Date:  2009-08-05       Impact factor: 5.258

5.  Is Acanthamoeba pathogenicity associated with intracellular bacteria?

Authors:  Graeme Neil Paterson; Michael Rittig; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Exp Parasitol       Date:  2011-07-13       Impact factor: 2.011

6.  Occurrence of bacterial endosymbionts in Acanthamoeba spp. isolated from corneal and environmental specimens and contact lenses.

Authors:  T R Fritsche; R K Gautom; S Seyedirashti; D L Bergeron; T D Lindquist
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

7.  Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts.

Authors:  Hans Peter Iseli; Michael A Thiel; Farhad Hafezi; Juergen Kampmeier; Theo Seiler
Journal:  Cornea       Date:  2008-06       Impact factor: 2.651

Review 8.  Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

Authors:  Govinda S Visvesvara; Hercules Moura; Frederick L Schuster
Journal:  FEMS Immunol Med Microbiol       Date:  2007-04-11

9.  Detection of bacterial endosymbionts in clinical acanthamoeba isolates.

Authors:  Alfonso Iovieno; Dolena R Ledee; Darlene Miller; Eduardo C Alfonso
Journal:  Ophthalmology       Date:  2010-01-19       Impact factor: 12.079

10.  Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report.

Authors:  Leopoldo Garduño-Vieyra; Claudia R Gonzalez-Sanchez; Sergio E Hernandez-Da Mota
Journal:  Case Rep Ophthalmol       Date:  2011-08-31
View more
  3 in total

1.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

Review 2.  Collagen Cross-linking for Microbial Keratitis.

Authors:  Prashant Garg; Sujata Das; Aravind Roy
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jan-Mar

3.  The Effect of Anti-Amoebic Agents and Ce6-PDT on Acanthamoeba castellanii Trophozoites and Cysts, In Vitro.

Authors:  Lei Shi; Vithusan Muthukumar; Tanja Stachon; Lorenz Latta; Mohamed Ibrahem Elhawy; Gubesh Gunaratnam; Erika Orosz; Berthold Seitz; Albrecht F Kiderlen; Markus Bischoff; Nóra Szentmáry
Journal:  Transl Vis Sci Technol       Date:  2020-11-23       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.